OTC Consumer Health Recruiters

Over-the-counter drug products — from pain relievers and antacids to topical analgesics, cough and cold products, and OTC acne treatments — operate under the most rigorous regulatory framework in consumer health. The FDA OTC drug monograph system, NDAs, and the recent OTC Monograph Reform (CARES Act) have created a complex and rapidly evolving compliance environment. Companies in this space need executives who understand the regulatory framework deeply — not peripherally.

NutraHire recruits for OTC consumer health companies across the category spectrum — from large multi-category OTC drug portfolios to emerging brands launching single-indication OTC products. We also recruit for companies navigating the Rx-to-OTC switch pathway, which requires a unique combination of regulatory expertise, clinical evidence management, and commercial launch planning. Our network includes candidates who have operated at the intersection of pharmaceutical regulatory affairs and consumer health commercial strategy.

Key Roles We Place in OTC Consumer Health

• VP of Regulatory Affairs (OTC drugs, ANDA, NDA, monograph compliance)
• VP of Medical Affairs and Clinical Development
• VP of Sales (mass, drug, club, DTC)
• VP of Marketing and Brand (OTC drug advertising compliance)
• Director of Pharmacovigilance and Adverse Event Reporting
• VP of Operations and Quality (pharmaceutical GMP, 21 CFR Part 211)
• Director of Regulatory Strategy (Rx-to-OTC switch)
• National Account Director (Walgreens, CVS, Walmart, Rite Aid)
• R&D Director and Drug Product Development Scientist

The OTC Monograph Reform Impact

The Over-the-Counter Monograph Reform enacted as part of the CARES Act in 2020 fundamentally changed how OTC drug products are regulated. Administrative Order requirements, user fee programs, and new timelines for monograph updates have significantly increased the regulatory workload for OTC drug companies. Regulatory Affairs VPs and Directors who understand the new administrative order system, GDUFA-equivalent timelines, and the OTC drug monograph database are in exceptional demand.

Rx-to-OTC Switch: A Specialized Capability

The Rx-to-OTC switch pathway requires regulatory leaders who can manage FDA advisory committee preparation, labeling development for consumer comprehension studies, and the commercial launch strategy for a newly switched OTC drug. This is one of the most specialized and highest-value regulatory competencies in consumer health — and it requires a recruiting partner who can find and evaluate it accurately.

Compensation Benchmarks

VP of Regulatory Affairs (OTC): $185K–$240K. VP of Medical Affairs: $195K–$255K. VP of Sales: $170K–$225K. Pharmacovigilance Directors: $155K–$205K. VP of Operations (pharma GMP): $160K–$210K. Regulatory Strategy Directors (Rx-to-OTC): $175K–$225K.